KALV earnings: a negative outcome, -13.5%

On March 10, 2020, KalVista Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -13.5% in the window around the event. It had already run -14.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.